Cargando…

Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer

CEACAM1 is associated with malignant potential of various cancers. The current study aims to clarify the association between carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression and malignant potential of gastric cancer and to address whether CEACAM1 cytoplasmic domain isof...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Akihiro, Yokoyama, Shozo, Nakamori, Mikihito, Nakamura, Masaki, Ojima, Toshiyasu, Yamaguchi, Shunsuke, Mitani, Yasuyuki, Shively, John E., Yamaue, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722051/
https://www.ncbi.nlm.nih.gov/pubmed/31481751
http://dx.doi.org/10.1038/s41598-019-49230-w
_version_ 1783448450938961920
author Takeuchi, Akihiro
Yokoyama, Shozo
Nakamori, Mikihito
Nakamura, Masaki
Ojima, Toshiyasu
Yamaguchi, Shunsuke
Mitani, Yasuyuki
Shively, John E.
Yamaue, Hiroki
author_facet Takeuchi, Akihiro
Yokoyama, Shozo
Nakamori, Mikihito
Nakamura, Masaki
Ojima, Toshiyasu
Yamaguchi, Shunsuke
Mitani, Yasuyuki
Shively, John E.
Yamaue, Hiroki
author_sort Takeuchi, Akihiro
collection PubMed
description CEACAM1 is associated with malignant potential of various cancers. The current study aims to clarify the association between carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression and malignant potential of gastric cancer and to address whether CEACAM1 cytoplasmic domain isoform balance modulates the properties of gastric cancer cells. Immunohistochemical analyses for CEACAM1 were performed in 235 patients with gastric cancer who underwent surgery. Risk factors for overall survival and peritoneal metastasis were calculated based on CEACAM1 expression in the gastric cancer tissue. Patients with CEACAM1 long (CEACAM1-L) or short (CEACAM1-S) cytoplasmic isoform dominance were compared with patients with null CEACAM1 expression in terms of overall survival. CEACAM1 transfected or knockdown gastric cancer cell line, NUGC3 and MKN7 cells, were examined by invasion assay and three dimensional (3D) culture, in order to clarify whether CEACAM1 modulate invasion, lumen formation and tumor growth of gastric cancer cells. Multivariate analysis demonstrated that gastric cancer without CEACAM1 is an independent prognostic factor and a risk factor for peritoneal dissemination. Patients with CEACAM1-S dominance had better prognosis than those with CEACAM1-L. CEACAM1-4L overexpression induced less invasion, more lumen formation, and less tumor growth of NUGC3 cells. CEACAM1-4S overexpression had less invasion and more lumen formations, but not less tumor growth. Knockdown of CEACAM1 expression had less invasion, but not less lumen formations of MKN7 cells. Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer. Expression of CEACAM1 in gastric cancer cells modulates invasiveness, lumen formation, and tumor growth.
format Online
Article
Text
id pubmed-6722051
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67220512019-09-17 Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer Takeuchi, Akihiro Yokoyama, Shozo Nakamori, Mikihito Nakamura, Masaki Ojima, Toshiyasu Yamaguchi, Shunsuke Mitani, Yasuyuki Shively, John E. Yamaue, Hiroki Sci Rep Article CEACAM1 is associated with malignant potential of various cancers. The current study aims to clarify the association between carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression and malignant potential of gastric cancer and to address whether CEACAM1 cytoplasmic domain isoform balance modulates the properties of gastric cancer cells. Immunohistochemical analyses for CEACAM1 were performed in 235 patients with gastric cancer who underwent surgery. Risk factors for overall survival and peritoneal metastasis were calculated based on CEACAM1 expression in the gastric cancer tissue. Patients with CEACAM1 long (CEACAM1-L) or short (CEACAM1-S) cytoplasmic isoform dominance were compared with patients with null CEACAM1 expression in terms of overall survival. CEACAM1 transfected or knockdown gastric cancer cell line, NUGC3 and MKN7 cells, were examined by invasion assay and three dimensional (3D) culture, in order to clarify whether CEACAM1 modulate invasion, lumen formation and tumor growth of gastric cancer cells. Multivariate analysis demonstrated that gastric cancer without CEACAM1 is an independent prognostic factor and a risk factor for peritoneal dissemination. Patients with CEACAM1-S dominance had better prognosis than those with CEACAM1-L. CEACAM1-4L overexpression induced less invasion, more lumen formation, and less tumor growth of NUGC3 cells. CEACAM1-4S overexpression had less invasion and more lumen formations, but not less tumor growth. Knockdown of CEACAM1 expression had less invasion, but not less lumen formations of MKN7 cells. Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer. Expression of CEACAM1 in gastric cancer cells modulates invasiveness, lumen formation, and tumor growth. Nature Publishing Group UK 2019-09-03 /pmc/articles/PMC6722051/ /pubmed/31481751 http://dx.doi.org/10.1038/s41598-019-49230-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Takeuchi, Akihiro
Yokoyama, Shozo
Nakamori, Mikihito
Nakamura, Masaki
Ojima, Toshiyasu
Yamaguchi, Shunsuke
Mitani, Yasuyuki
Shively, John E.
Yamaue, Hiroki
Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title_full Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title_fullStr Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title_full_unstemmed Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title_short Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
title_sort loss of ceacam1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722051/
https://www.ncbi.nlm.nih.gov/pubmed/31481751
http://dx.doi.org/10.1038/s41598-019-49230-w
work_keys_str_mv AT takeuchiakihiro lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT yokoyamashozo lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT nakamorimikihito lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT nakamuramasaki lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT ojimatoshiyasu lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT yamaguchishunsuke lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT mitaniyasuyuki lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT shivelyjohne lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer
AT yamauehiroki lossofceacam1isassociatedwithpoorprognosisandperitonealdisseminationofpatientswithgastriccancer